TERUMO CORPORATION, ASHITAKA CAPIOX FX25 OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS
|
Back to Search Results |
|
Model Number N/A |
Device Problem
Increase in Pressure (1491)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 01/14/2023 |
Event Type
Injury
|
Event Description
|
The user facility reported that during on-pump, pressure at the venous blood inlet port on the capiox device increased.There was no problem in the gas exchange performance.The blood flow rate was not sufficient; therefore, the oxygenator was changed out.The procedure was performed swiftly, and the patient was not harmed.There was no patient injury or surgical intervention required.The procedure outcome was not reported.The final patient impact was not harmed.
|
|
Manufacturer Narrative
|
Udi: n/a as this product code is not exported to the us market.Implanted date: device was not implanted.Explanted date: device was not explanted.Initial reporter occupation: clinical engineer.Pma/510(k): k130280.The actual device has been returned for evaluation.Visual inspection of the actual sample upon receipt found no breakage in the appearance.Physiological saline solution was flowed by gravity into the actual sample.As a result, formation of blood clots was observed over the oxygenation module entirely.The actual sample was filled with glutaraldehyde-containing saline solution and fixed, and then the housing and the filter was removed.Visual inspection of the oxygenation module found formation of blood clots.There was no anomaly in fiber winding condition.The oxygenation module was inspected visually while the fiber layer was removed gradually.The amount of blood clots was found to be greater the further inside the gas exchange area.There was no anomaly in fiber winding condition.The heat exchanger was separated from the outer cylinder and subjected to visual and magnifying inspection.Blood clots were found sticking all over the heat exchanger.No deformation that could lead to a clogging was observed.Review of the manufacturing record and shipping inspection record of the actual sample found no anomaly in them.A search of the past complaint file found no other similar report with the involved product code/lot number.The investigation result showed formation of blood clots in the actual sample.As for the cause of this event, it was conceivable that blood clots formed due to some factor and clogged the oxygenator, leading to the increasing pressure at the venous blood inlet port.However, it was not possible to clarify the cause of blood clot formation from the condition of the actual sample.Relevant instructions for use (ifu) reference: "do not reduce heparin during circulation.Otherwise, blood clotting might occur.(warnings)." "adequate heparinization of the blood is required to prevent it from clotting in the system.(warnings)." terumo medical products (tmp) (importer) registration no.(b)(4) is submitting this report on behalf of ashitaka factory of terumo corporation (manufacturer) registration no.(b)(4).
|
|
Search Alerts/Recalls
|
|
|